Effects of flecainide on the electrophysiological properties of atrial vulnerability in humans

Circulation Journal

Volumn 67, Issue 5, 2003, Pages 437-442

  Yoshiga, Yasuhiro ^a   Shimizu, Akihiko ^a   Yamagata, Toshihiko ^a   Esato, Masahiro ^a   Ueyama, Takeshi ^a   Ohmura, Masato ^a   Itagaki, Kazuo ^a   Kimura, Masayasu ^a   Kakugawa, Hiroyuki ^a   Doi, Masahiro ^a   Matsuzaki, Masunori ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Atrial fibrillation; Atrial refractoriness; Atrial vulnerability; Flecainide

Indexed keywords

FLECAINIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONDUCTION DELAY ZONE; CORRELATION ANALYSIS; DRUG BLOOD LEVEL; ELECTROCARDIOGRAM; ELECTROPHYSIOLOGY; FEMALE; FRAGMENTED ATRIAL ACTIVITY ZONE; HEART ATRIUM FIBRILLATION; HEART CONDUCTION; HEART MUSCLE REFRACTORY PERIOD; HEART RIGHT ATRIUM; HUMAN; MALE; MAXIMUM CONDUCTION DELAY; PROSPECTIVE STUDY; REPETITIVE ATRIAL FIRING ZONE;

EID: 0038333645     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.67.437     Document Type: Article

References (30)

1. Goy JJ, Maendly R, Grbic M, Finci L, Sigwart U. Cardioversion with flecainide in patients with atrial fibrillation of recent onset. Eur J Clin Pharmacol 1985; 27: 737-738.
2. Goy JJ, Kaufmann U, Kappenberger L, Sigwart U. Restoration of sinus rhythm with flecainide in patients with atrial fibrillation. Am J Cardiol 1988; 62: 38D-40D.
3. Van Gelder IC, Crijns HJ, Van Gilst WH, Van Wijk LM, Hamer HP, Lie KI. Efficacy and safety of flecainide acetate in the maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation or atrial flutter. Am J Cardiol 1989; 64: 1317-1321.
4. Matsuo K, Kumagai K, Annoura M, Ideishi M, Arakawa K. Mechanism of antiarrhythmic effects of class Ic drugs in paroxysmal atrial fibrillation in man. Cardiology 1998; 89: 119-123.
5. Pop T, Treese N. Effect of intravenous flecainide on atrial vulnerability in man. Drugs 1985; 29(Suppl 4): 1-6.
6. Kidwell GA, Gonzalez MD. Effects of flecainide and D-sotalol on myocardial conduction and refractoriness: Relation to antiarrhythmic and proarrhythmic drug effects. J Cardiovasc Pharmacol. 1993; 21: 621-632.
7. Hashimoto H, Satoh N, Nakashima M. Effects of SUN-1165, N-(2,6-dimethylphenyl)-8-pyrrolizidine acetamide hydrochloride hemihydrate, a new class I antiarrhythmic drug, on ventricular arrhythmias, intraventricular conduction, and the refractory period in canine myocardial infarction. J Cardiovasc Pharmacol. 1992; 19: 417-424.
8. Esato M, Shimizu A, Chun YH, Tatsuno H, Yamagata T, Matsuzaki M. Electrophysiologic effects of a class I antiarrhythmic agent, cibenzoline, on the refractoriness and conduction of the human atrium in vivo. J Cardiovasc Pharmacol 1996; 28: 321-327.
9. Centurion OA, Shimizu A, Isomoto S, Konoe A, Hirata T, Hano O, et al. Repetitive atrial firing and fragmented atrial activity elicited by extrastimuli in the sick sinus syndrome with and without abnormal atrial electrograms. Am J Med Sci 1994; 307: 247-254.
10. Konoe A, Fukatani M, Tanigawa M, Isomoto S, Kadena M, Sakamoto T, et al. Electrophysiological abnormalities of the atrial muscle in patients with manifest Wolff-Parkinson-White syndrome associated with paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 1992; 15: 1040-1052.
11. Hashiba K, Centurion OA, Shimizu A. The electrophysiological characteristics of the human atrial muscle in paroxysmal atrial fibrillation. Am Heart J 1996; 131: 778-789.
12. Shimizu A, Fukatani M, Konoe A, Isomoto S, Centurion OA, Yano K. Electrophysiological effects of a new class III antiarrhythmic agent (E-4031) on the conduction and refractoriness of the in vivo human atrium. Cardiovasc Res 1993; 27: 1333-1338.
13. Shimizu A, Fukatani M, Tanigawa M, Kaibara M, Konoe A, Isomoto S, et al. Mechanism of the suppression of repetitive atrial firing by isoproterenol: Comparison with disopyramide. Int J Cardiol 1994; 43: 175-183.
14. Wyndham CR, Amat-y-Leon F, Wu D, Denes P, Dhingra R, Simpson R, et al. Effects of cycle length on atrial vulnerability. Circulation 1977; 55: 260-267.
15. Kumagai K, Akimitsu S, Kawahira K, Kawanami F, Yamanouchi Y, Hiroki T, et al. Electrophysiological properties in chronic lone atrial fibrillation. Circulation 1991; 84: 1662-1668.
16. Cosio FG, Palacios J, Vidal JM, Cocina EG, Gomez-Sanchez MA, Tamargo L. Electrophysiologic studies in atrial fibrillation: Slow conduction of premature impulses: A possible manifestation of the background for reentry. Am J Cardiol 1983; 51: 122-130.
17. Cosio FG, Llovet A, Vidal JM. Mechanism and clinical significance of atrial repetitive responses in man. Pacing Clin Electrophysiol 1983; 6: 53-59.
18. Tanigawa M, Fukatani M, Konoe A, Isomoto S, Kadena M, Hashiba K. Prolonged and fractionated right atrial electrograms during sinus rhythm in patients with paroxysmal atrial fibrillation and sick sinus node syndrome. J Am Coll Cardiol 1991; 17: 403-408.
19. Ohe T, Matsuhisa M, Kamakura S, Yamada J, Sato I, Nakajima K, et al. Relation between the widening of the fragmented atrial activity zone and atrial fibrillation. Am J Cardiol 1983; 52: 1219-1222.
20. Shimizu A, Fukatani M, Tanigawa M, Mori M, Hashiba K. Intraatrial conduction delay and fragmented atrial activity in patients with paroxysmal atrial fibrillation. Jpn Circ J 1989; 53: 1023-1030.
21. Piovan D, Padrini R, Furlanut M, Moretto R, Ferrari M. Plasma and tissue levels of flecainide in rats. Pharmacol Res Commun 1986; 18: 739-745.
22. Conard GJ, Ober RE. Metabolism of flecainide. Am J Cardiol 1984; 53: 41B-51B.
23. Boineau JP, Schuessler RB, Mooney CR, Miller CB, Wylds AC, Hudson RD, et al. Natural and evoked atrial flutter due to circus movement in dogs: Role of abnormal atrial pathways, slow conduction, nonuniform refractory period distribution and premature beats. Am J Cardiol 1980; 45: 1167-1181.
24. Kumagai K, Gondo N, Matsuo K, Annoura M, Moroe K, Nakashima Y, et al. Wavelength index: A predictor of the response to disopyramide in paroxysmal lone atrial fibrillation. Cardiology 1994; 85: 184-192.
25. Johnson N, Danilo P Jr, Wit AL, Rosen MR. Characteristics of initiation and termination of catecholamine-induced triggered activity in atrial fibers of the coronary sinus. Circulation 1986; 74: 1168-1179.
26. Boutjdir M, Le Heuzey JY, Lavergne T, Chauvaud S, Guize L, Carpentier A, et al. Inhomogeneity of cellular refractoriness in human atrium: Factor of arrhythmia? Pacing Clin Electrophysiol 1986; 9: 1095-1100.
27. Ramanna H, Hauer RN, Wittkampf FH, de Bakker JM, Wever EF, Elvan A, et al. Identification of the substrate of atrial vulnerability in patients with idiopathic atrial fibrillation. Circulation 2000; 101: 995-1001.
28. Moriguchi M, Niwano S, Yoshizawa N, Kitano Y, Kojima J, Inuo K, et al. Inhomogeneity in the appearance of electrical remodeling during chronic rapid atrial pacing: Evaluation of the dispersion of atrial effective refractoriness. Jpn Circ J 2001; 65: 335-340.
29. Watanabe T, Yamaki M, Tachibana H, Yamauchi S, Kubota I, Tomoike H. Anisotropic effects of sodium channel blockers on the wavelength for ventricular excitation in dogs. Jpn Circ J. 2000; 64: 689-694.
30. Nagata Y. Flecainide augments muscle sympathetic nerve activity in humans. Circ J 2002; 66: 377-381.